Magaton Isotta Martha, Siercks Ikbale, Nordin Martina, Popovici Roxana Maria, Boogen Eva Maria, Eisenhardt Stefan, Reeka Natalie, Lanowski Jan-Simon, Roumet Marie, von Wolff Michael
Division of Gynaecological Endocrinology and Reproductive Medicine, Inselspital University Hospital, Friedbuehlstrasse 19, 3010, Bern, Switzerland.
Institute for Gynaecological Endocrinology and Reproductive Medicine, c/o YUNA Praxis AG, Brauerstrasse 95, 9016, St. Gallen, Switzerland.
J Assist Reprod Genet. 2025 May 28. doi: 10.1007/s10815-025-03508-3.
The aim of this research is to assess the development potential of oocytes and zygotes obtained from Natural cycle IVF (NC-IVF), different minimal stimulation IVF (Min stim-IVF) and conventionally stimulated IVF (cIVF) treatment protocols.
International multi-centre retrospective cohort study including 1483 NC-IVF, 1208 Min stim-IVF, and 1892 cIVF cycles performed in 8 IVF centres between 01.2022 and 03.2023. The five Min stim-IVF protocols analysed included low dose clomiphene citrate, aromatase inhibitors, low dose (≤ 100 IU) gonadotropins, each alone or in combination. For each IVF protocol, we assessed and modelled the transition probabilities of (i) each observed oocyte developing into a zygote, (ii) each observed zygote developing into a gestational sac and (iii) each observed zygote developing into a live birth.
All modelled transition probabilities were found to be maximal in NC-IVF, minimal in cIVF with Min stim-IVF in between. The probability of transition from oocyte to zygote was 0.72 for NC-IVF, 0.56 to 0.65 for Min stim-IVF protocols and 0.54 for cIVF. The probability of transition from zygote to gestational sac was 0.21 for NC-IVF, 0.14 to 0.19 for Min stim-IVF and 0.09 for cIVF protocols and from zygote to live birth 0.16 for NC-IVF, 0.09 to 0.16 for Min stim-IVF and 0.06 for cIVF protocols.
The transition probabilities of oocytes and zygotes appears to be higher in NC-IVF, followed by Min stim-IVF and then cIVF, suggesting that increasing dosages of gonadotropins might have a negative effect on oocyte/zygote development potential.
Clinicaltrial.gov: NCT05125497. Registration date 03.11.2021.
本研究旨在评估从自然周期体外受精(NC-IVF)、不同的微刺激体外受精(Min stim-IVF)和常规刺激体外受精(cIVF)治疗方案中获得的卵母细胞和受精卵的发育潜力。
国际多中心回顾性队列研究,纳入了2022年1月至2023年3月期间在8个体外受精中心进行的1483个NC-IVF周期、1208个Min stim-IVF周期和1892个cIVF周期。分析的五种Min stim-IVF方案包括低剂量枸橼酸氯米芬、芳香化酶抑制剂、低剂量(≤100 IU)促性腺激素,每种单独使用或联合使用。对于每种体外受精方案,我们评估并模拟了以下转变概率:(i)每个观察到的卵母细胞发育成受精卵,(ii)每个观察到的受精卵发育成妊娠囊,(iii)每个观察到的受精卵发育成活产。
所有模拟的转变概率在NC-IVF中最高,在cIVF中最低,Min stim-IVF介于两者之间。从卵母细胞到受精卵的转变概率在NC-IVF中为0.72,在Min stim-IVF方案中为0.56至0.65,在cIVF中为0.54。从受精卵到妊娠囊的转变概率在NC-IVF中为0.21,在Min stim-IVF中为0.14至0.19,在cIVF方案中为0.09;从受精卵到活产的转变概率在NC-IVF中为0.16,在Min stim-IVF中为0.09至0.16,在cIVF方案中为0.06。
卵母细胞和受精卵的转变概率在NC-IVF中似乎更高,其次是Min stim-IVF,然后是cIVF,这表明促性腺激素剂量的增加可能对卵母细胞/受精卵的发育潜力有负面影响。
Clinicaltrial.gov:NCT05125497。注册日期2021年11月3日。